Annotated Medicine and Device Lists


Doxycycline

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.5.3.1. For curative treatment Others observations:
For use only in combination with quinine.
PAHO Strategic Fund Medicine List 2.1. Antibacterial No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Antibiotics Tetracyclines No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 02. Antibióticos No observations
El Salvador - 2019 ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.01 ANTIBIOTICS No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 12.03 DRUGS USED IN SEXUALLY TRANSMITTED INFECTIONS No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8:12 Antibiotics and Antifungals No observations
Haiti. National List of Essential Medicines 06.02.02 Other Antibacterials Age or weight restriction: > 8 yrs
Others observations:
Not to be used by pregnant women and children under 8 years old.

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS QUE MODIFICAN LA LIBERACIÓN DEL PRINCIPIO ACTIVO
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.02. ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.1. Access group antibiotics Age or weight restriction: Use in children <8 years only for life-threatening infections when no alternative exists.
This medicine requires a children care specialist.
Haiti. National List of Essential Medicines 06.02.02 Other Antibacterials Age or weight restriction: > 8 yrs
Others observations:
Not to be used by pregnant women and children under 8 years old.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.1. Access group antibiotics Age or weight restriction: Use in children <8 years only for life-threatening infections when no alternative exists.
This medicine requires a children care specialist.
Haiti. National List of Essential Medicines 06.02.02 Other Antibacterials Age or weight restriction: > 8 yrs
Others observations:
Not to be used by pregnant women and children under 8 years old.

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
WHO Model List of Essential Medicines 2019 6.2.1. Access group antibiotics Age or weight restriction: Use in children <8 years only for life-threatening infections when no alternative exists.
This medicine requires a children care specialist.
Barbados. Barbados National Drug Formulary (BNDF) 08.12.24 Tetracyclines No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.1. Access group antibiotics Age or weight restriction: Use in children <8 years only for life-threatening infections when no alternative exists.
This medicine requires a children care specialist.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.2.1. Access group antibiotics This medicine requires a children care specialist.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.5.3.2 For chemoprevention Age or weight restriction: >8 years.
Others observations:
>8 years.
PAHO Strategic Fund Medicine List 2.1. Antibacterial No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 01 ANTIBACTERIANOS PARA USO SISTÉMICO No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
DOXICICLINA MONOHIDRATO X 10 TABLETAS
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 01 ANTIBACTERIANOS PARA USO SISTÉMICO No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.02. ANTIBACTERIANOS Others observations:
Alternativa
Guyana. Essential Medicines List. 2020-2021 7.02.10 Tetracyclines No observations
Guyana. Essential Medicines List. 2020-2021 Reserve second-line medicines used to treat Malaria No observations
Suriname. NGK-C-011 6.04 Anti-bacterial agents: Other No observations
Suriname. NGK-C-011 6.10 Anti-Protozoan Agents: Anti-Malaria Agents No observations
Haiti. National List of Essential Medicines 06.05.03.01 For curative treatment Others observations:
For use only in combination with quinine
Haiti. National List of Essential Medicines 06.05.03.02 For prophylaxis Others observations:
For use only in combination with quinine
Barbados. Barbados National Drug Formulary (BNDF) 08.12.24 Tetracyclines No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Chile. Formulario Nacional de Medicamentos. 2005 06.02. ANTIBACTERIANOS Others observations:
Alternativa

This medicine is present in:

List Section Observation
Peru 6.2.2.5 Tetracyclines No observations
Peru 6.5.3 Antimalarials No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.5.3.1. For curative treatment Others observations:
For use only in combination with quinine.

Information Resources: Doxycycline

Loading ...
Loading ...
Loading ...
No information available